|
Volumn 45, Issue 6, 2001, Pages
|
Maintaining mitochondrial membrane impermeability: An opportunity for new therapy in glaucoma?
|
Author keywords
Apoptosis; Glaucoma; Mitochondrial membrane permeability; Retinal ganglion cell loss
|
Indexed keywords
AMINE;
BRIMONIDINE;
PROPARGYLAMINE DERIVATIVE;
PROTEIN BCL 2;
PROTEIN BCL X;
PROTEIN KINASE B;
UNCLASSIFIED DRUG;
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CELL PROTEIN;
BCL2L1 PROTEIN, HUMAN;
DRUG DERIVATIVE;
PARGYLINE;
PROPARGYLAMINE;
PROPYLAMINE;
QUINOXALINE DERIVATIVE;
APOPTOSIS;
CELL DEGENERATION;
CELL SURVIVAL;
GLAUCOMA;
INTRAOCULAR PRESSURE ABNORMALITY;
MEMBRANE PERMEABILITY;
MITOCHONDRIAL MEMBRANE;
NONHUMAN;
OPTIC NERVE;
PHOSPHORYLATION;
PRIORITY JOURNAL;
RETINA GANGLION CELL;
REVIEW;
CELL LOSS;
CONFERENCE PAPER;
DISEASE ACTIVITY;
HUMAN;
MITOCHONDRIAL RESPIRATION;
NERVE CELL DEGENERATION;
NEUROPROTECTION;
PROTEIN PHOSPHORYLATION;
ANIMAL;
CELL MEMBRANE PERMEABILITY;
DRUG EFFECT;
INTRAOCULAR PRESSURE;
METABOLISM;
MITOCHONDRION;
SIGNAL TRANSDUCTION;
ANIMALS;
APOPTOSIS;
BCL-X PROTEIN;
CELL MEMBRANE PERMEABILITY;
GLAUCOMA;
HUMANS;
INTRAOCULAR PRESSURE;
MITOCHONDRIA;
PARGYLINE;
PROPYLAMINES;
PROTO-ONCOGENE PROTEINS C-BCL-2;
QUINOXALINES;
RETINAL GANGLION CELLS;
SIGNAL TRANSDUCTION;
|
EID: 0034757151
PISSN: 00396257
EISSN: None
Source Type: Journal
DOI: 10.1016/S0039-6257(01)00207-7 Document Type: Article |
Times cited : (55)
|
References (85)
|